Cisplatin and capecitabine
WebIn this study, neoadjuvant chemotherapy with the triplet regimen of albumin-bound paclitaxel with cisplatin and capecitabine (APCC regimen) for locally advanced resectable ESCC showed high anti-tumor activities and significant effect on tumour downstaging. None of the evaluable patients (n=30) had disease progression after chemotherapy. WebApr 11, 2024 · Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro …
Cisplatin and capecitabine
Did you know?
WebMay 8, 2024 · The ACTICCA-1 study initially explored the use of adjuvant gemcitabine and cisplatin after surgery compared with surveillance alone. With the results of BILCAP, however, ACTICCA-1 amended the control arm to include adjuvant capecitabine. SWOG is planning an adjuvant study in North America as well, Dr. Shroff said. WebEffect of Capecitabine Maintenance Therapy Plus Best Supportive Care vs Best Supportive Care Alone on Progression-Free Survival Among Patients With Newly Diagnosed Metastatic Nasopharyngeal Carcinoma Who Had Received Induction Chemotherapy: A Phase 3 Randomized Clinical Trial Clinical Pharmacy and Pharmacology JAMA Oncology …
WebOct 6, 2014 · New first-line regimens demonstrated equivalence (epirubicin, cisplatin, and capecitabine [ECX]; epirubicin, oxaliplatin, and capecitabine [EOX]; and mFOLFOX) or … WebApr 15, 2024 · A 52-year-old man developed mucositis and weight loss during treatment with cisplatin for high-grade squamous cell carcinoma (SCC) of the left nasal cavity …
WebThe cisplatin dose of 60 mg/m 2 and capecitabine dose of 1000 mg/m 2 twice daily on days 1 to 14 were used in previous trials. 23,30 In our trial, adding the paclitaxel and … WebEffect of Induction Chemotherapy With Paclitaxel, Cisplatin, and Capecitabine vs Cisplatin and Fluorouracil on Failure-Free Survival for Patients With Stage IVA to IVB …
WebApr 11, 2024 · Patients will be treated with anlotinib, penpulimab and capecitabine every three weeks until PD or intolerance to toxicity. ... He X, Zhang B, Yang Q, Zhang X, Zou J, Fang W, Zhang L. Camrelizumab versus placebo in combination with gemcitabine and cisplatin as first-line treatment for recurrent or metastatic nasopharyngeal carcinoma …
WebOct 6, 2014 · To compare epirubicin, cisplatin, and capecitabine (ECX) with fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first-line treatments in patients with advanced gastric or esophagogastric junction (EGJ) adenocarcinoma. Patients and Methods This open, randomized, phase III study was carried out in 71 centers. havana cuba in spanishWebUsually you have a combination of 2 or 3 drugs (in a regimen). Your oncologist will explain which regimen they think is best for you. The most common types are: fluorouracil, folinic acid, oxaliplatin and docetaxel (FLOT) epirubicin, cisplatin and capecitabine (ECX) epirubicin, cisplatin and fluorouracil (ECF) havana cuba live webcamWebConclusions: Epirubicin, cisplatin, and capecitabine seems to be active in platinum-resistant relapsed EOC with manageable toxicity. Further prospective investigation of platinum-anthracycline combinations is warranted in patients who relapse 3 to 6 months after first-line platinum-taxane treatment. Publication types Clinical Trial MeSH terms havana cuba in the 1800sWebFeb 19, 2024 · Specifically, both cisplatin(IV) and capecitabine are located in the core of the CM resulting in effective protection mechanism. Additionally, the other protection … bored horseWebConclusions: Camrelizumab and apatinib combined with induction chemotherapy of NAB-paclitaxel, cisplatin and capecitabine and CCRT shows excellent distant metastatic control with acceptable safety, which is a new promising and effective systemic therapy regimen for high-risk of metastatic NPC patients. Clinical trial information: ChiCTR2000032317. bored in amharicWebThe National Comprehensive Cancer Network (NCCN) recommends the use of capecitabine (Xeloda) for other certain types of cancer. These cancers include pancreatic, esophageal, stomach, and throat cancers, among others. Since capecitabine (Xeloda) is only FDA-approved for colon, colorectal, and breast cancer, the use of this medication … bored homeWebThis study looks at outcomes for cisplatin plus capecitabine (PX) outside of a trial setting. Methods: Cisplatin (mean dose 75 mg/m²) was given on day 1 of a 3-week cycle and … havana cuba itinerary